TORONTO (AP) _ Intellipharmaceutics International Inc. (IPCI) on Tuesday reported a loss of $2.6 million in its fiscal third quarter.
The Toronto-based company said it had a loss of 8 cents per share.
The extended-release drug developer posted revenue of $1.2 million in the period.
In the final minutes of trading on Tuesday, the company's shares hit $1.15. A year ago, they were trading at $2.84.